DE3409237A1 - Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel - Google Patents

Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Info

Publication number
DE3409237A1
DE3409237A1 DE19843409237 DE3409237A DE3409237A1 DE 3409237 A1 DE3409237 A1 DE 3409237A1 DE 19843409237 DE19843409237 DE 19843409237 DE 3409237 A DE3409237 A DE 3409237A DE 3409237 A1 DE3409237 A1 DE 3409237A1
Authority
DE
Germany
Prior art keywords
methyl
deep
acetyl
dihydro
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19843409237
Other languages
German (de)
English (en)
Inventor
Wolfgang Dipl.-Chem. Dr. Eberlein
Wolfhard Dipl.-Chem. Dr. 7950 Biberach Engel
Antonio Prof. Dr. Mailand/Milano Giachetti
Rudolf Dr. Hammer
Gerhard Dipl.-Chem. Dr. Mihm
Günther Dipl.-Chem. Dr. 7950 Biberach Schmidt
Günter Dipl.-Chem. Dr. 7951 Warthausen Trummlitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Priority to DE19843409237 priority Critical patent/DE3409237A1/de
Priority to ZA851871A priority patent/ZA851871B/xx
Priority to AT85102387T priority patent/ATE44744T1/de
Priority to EP85102387A priority patent/EP0156191B1/de
Priority to DE8585102387T priority patent/DE3571620D1/de
Priority to PH31947A priority patent/PH21031A/en
Priority to GR850612A priority patent/GR850612B/el
Priority to DD85274054A priority patent/DD235260A5/de
Priority to IL74573A priority patent/IL74573A/xx
Priority to JP60050229A priority patent/JPS60215683A/ja
Priority to HU85939A priority patent/HU192272B/hu
Priority to NO850992A priority patent/NO161371C/no
Priority to DK114985A priority patent/DK171023B1/da
Priority to AU39815/85A priority patent/AU571315B2/en
Priority to ES541212A priority patent/ES8607282A1/es
Priority to IE64585A priority patent/IE58237B1/en
Priority to PT80097A priority patent/PT80097B/pt
Priority to FI850991A priority patent/FI81342C/fi
Priority to CA000476368A priority patent/CA1244016A/en
Priority to NZ211425A priority patent/NZ211425A/en
Priority to US06/711,913 priority patent/US4550107A/en
Priority to KR1019850001629A priority patent/KR920003980B1/ko
Publication of DE3409237A1 publication Critical patent/DE3409237A1/de
Priority to ES551277A priority patent/ES8702908A1/es
Priority to ES551276A priority patent/ES8701750A1/es
Priority to CS914096A priority patent/CS409691A3/cs
Priority to MX9202791A priority patent/MX9202791A/es
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Tests Of Electric Status Of Batteries (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Toys (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DE19843409237 1984-03-14 1984-03-14 Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel Withdrawn DE3409237A1 (de)

Priority Applications (26)

Application Number Priority Date Filing Date Title
DE19843409237 DE3409237A1 (de) 1984-03-14 1984-03-14 Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ZA851871A ZA851871B (en) 1984-03-14 1985-01-13 Condensed diazepinones processes for preparing them and pharmaceutical compositions containing these compounds
AT85102387T ATE44744T1 (de) 1984-03-14 1985-03-04 Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
EP85102387A EP0156191B1 (de) 1984-03-14 1985-03-04 Kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE8585102387T DE3571620D1 (en) 1984-03-14 1985-03-04 Condensed diazepinones, process for their preparation and medicaments containing these compounds
PH31947A PH21031A (en) 1984-03-14 1985-03-06 Condensed diazepinones, pharmaceutical composition containing same and method of using said compound
GR850612A GR850612B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-03-14 1985-03-11
DD85274054A DD235260A5 (de) 1984-03-14 1985-03-12 Verfahren zur herstellung neuer kondensierter diazepinone
IL74573A IL74573A (en) 1984-03-14 1985-03-12 ((aminoalkyl)cyclic amino)alkanoyl-condensed benzodiazepinones,their preparation and pharmaceutical compositions containing them
AU39815/85A AU571315B2 (en) 1984-03-14 1985-03-13 Diazepinone derivatives
CA000476368A CA1244016A (en) 1984-03-14 1985-03-13 Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds
NO850992A NO161371C (no) 1984-03-14 1985-03-13 Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
DK114985A DK171023B1 (da) 1984-03-14 1985-03-13 Basisk substituerede tricykliske diazepinoner, fremgangsmåde til deres fremstilling og lægemiddel indeholdende sådanne forbindelser
JP60050229A JPS60215683A (ja) 1984-03-14 1985-03-13 新規縮合ジアゼピノン
ES541212A ES8607282A1 (es) 1984-03-14 1985-03-13 Procedimiento de preparar nuevas diazepinonas condensadas
IE64585A IE58237B1 (en) 1984-03-14 1985-03-13 Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds
PT80097A PT80097B (pt) 1984-03-14 1985-03-13 Processo para a preparacao de diazepinonas condensadas e de composicoes farmaceuticas contendo estes compostos
FI850991A FI81342C (fi) 1984-03-14 1985-03-13 Foerfarande foer framstaellning av farmaceutiskt vaerdefulla basiskt substituerade tricykliska diazepinoner.
HU85939A HU192272B (en) 1984-03-14 1985-03-13 Process for production of condensated diasepinons
NZ211425A NZ211425A (en) 1984-03-14 1985-03-13 Diazepines and pharmaceutical compositions
US06/711,913 US4550107A (en) 1984-03-14 1985-03-14 Condensed diazepinones, their compositions and methods of use as pharmaceuticals
KR1019850001629A KR920003980B1 (ko) 1984-03-14 1985-03-14 축합 디아제핀온의 제조방법
ES551277A ES8702908A1 (es) 1984-03-14 1986-01-27 Procedimiento de preparar nuevas diazepinonas condensadas
ES551276A ES8701750A1 (es) 1984-03-14 1986-01-27 Procedimiento de preparar nuevas diazepinonas condensadas
CS914096A CS409691A3 (en) 1984-03-14 1991-12-27 Condensed diazepinones, process of their preparation and pharmaceuticalcompositions containing them
MX9202791A MX9202791A (es) 1984-03-14 1992-06-11 Diazepinonas condesadas y procedimiento para su preparacion.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843409237 DE3409237A1 (de) 1984-03-14 1984-03-14 Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DE3409237A1 true DE3409237A1 (de) 1985-09-19

Family

ID=6230402

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19843409237 Withdrawn DE3409237A1 (de) 1984-03-14 1984-03-14 Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE8585102387T Expired DE3571620D1 (en) 1984-03-14 1985-03-04 Condensed diazepinones, process for their preparation and medicaments containing these compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8585102387T Expired DE3571620D1 (en) 1984-03-14 1985-03-04 Condensed diazepinones, process for their preparation and medicaments containing these compounds

Country Status (23)

Country Link
US (1) US4550107A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0156191B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS60215683A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR920003980B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE44744T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU571315B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1244016A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS409691A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD235260A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE3409237A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK171023B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (3) ES8607282A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI81342C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR850612B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU192272B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE58237B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL74573A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9202791A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO161371C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ211425A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH21031A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT80097B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA851871B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333315A1 (en) * 1988-02-12 1989-09-20 Dr. Lo. Zambeletti S.p.A. Azacyclic compounds, processes for their preparation and their pharmaceutical use
EP0411567A1 (de) * 1989-07-31 1991-02-06 ARZNEIMITTELWERK DRESDEN GmbH Neue 5-(omega-Aminoacyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]-diazepin-11-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO1991017116A1 (en) * 1990-04-28 1991-11-14 Dr. Lo. Zambeletti S.P.A. Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
EP0515796A1 (de) * 1991-05-25 1992-12-02 ARZNEIMITTELWERK DRESDEN GmbH Neue 5-Aminoacyl-5.10-dihydro-11H-dibenzo/b,e/1,4/diazepin-11-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683217D1 (de) * 1985-06-27 1992-02-13 Thomae Gmbh Dr K In 11-stellung substituierte 5,11-dihydro-6h-pyrido-(2,3-b)(1,4)benzodiazepin-6-one, verfahren zur ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3529372A1 (de) * 1985-08-16 1987-02-19 Dompe Farmaceutici Spa Aminoacyl-derivat von 4,9-dihydro-10h-pyrido(3,2-b)-thieno(3,2-e) (1,4)-diazepinon und von 4,9-dihydro-10h-pyrido(3,2-b)thieno(3,4-e) (1,4)diazepinon, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE3531682A1 (de) * 1985-09-05 1987-03-12 Thomae Gmbh Dr K (+)-6-chlor-5,10-dihydro-5-((1-methyl-4- piperidinyl)acetyl)-11h-dibenzo(b,e)(1,4) diazepin-11-on, seine isolierung und verwendung als arzneimittel
JPS62107216A (ja) * 1985-11-05 1987-05-18 Ngk Insulators Ltd バルブシートインサート及びその製造法並びにそれを使用してなるシリンダーヘッド
DE3626095A1 (de) * 1986-07-31 1988-02-11 Thomae Gmbh Dr K Neue substituierte pyrido(2,3-b)(1,4)benzodiazepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3643666A1 (de) * 1986-12-20 1988-06-30 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3726908A1 (de) * 1987-08-13 1989-02-23 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3735895A1 (de) * 1987-10-23 1989-05-03 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3802334A1 (de) * 1988-01-27 1989-08-10 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3819444A1 (de) * 1988-06-08 1989-12-14 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3820347A1 (de) * 1988-06-15 1989-12-21 Thomae Gmbh Dr K Verwendung von in 11-stellung substituierten 5,11-dihydro-6h-pyrido(2,3-b) (1,4)benzodiazepin-6-onen zur behandlung von bradycardien und bradyarrhythmien in der human- und veterinaermedizin
US4931436A (en) * 1988-08-09 1990-06-05 Dr. Karl Thomae Gmbh Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds
US5179090A (en) * 1989-09-11 1993-01-12 Klaus Rudolf Condensed diazepinones and medicaments containing these compounds
DE4112014A1 (de) * 1991-04-12 1992-10-15 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung
US5324832A (en) * 1991-07-03 1994-06-28 The United States Of America As Represented By The Department Of Health And Human Services Muscarinic antagonists
US5716952A (en) * 1992-03-18 1998-02-10 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
WO2023190663A1 (ja) 2022-03-30 2023-10-05 参天製薬株式会社 高純度化合物の製造方法および精製方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795183B1 (de) * 1968-08-20 1972-07-20 Thomae Gmbh Dr K 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate und Arzneimittel
IL62792A (en) * 1980-05-07 1985-02-28 Byk Gulden Lomberg Chem Fab Acylated dihydrothienodiazepinone compounds,process for their preparation,and medicaments containing them
DE3028001A1 (de) * 1980-07-24 1982-02-18 Dr. Karl Thomae Gmbh, 7950 Biberach Neue, in 5-stellung substituierte 5,10-dihydro-11h-dibenzo (b,e)(1,4) diazepin-11-one, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DE3262922D1 (en) * 1981-02-02 1985-05-15 Byk Gulden Lomberg Chem Fab Tricyclic pyrrols, process for their preparation, their use and compositions containing them
DE3204153A1 (de) * 1982-02-06 1983-08-11 Dr. Karl Thomae Gmbh, 7950 Biberach Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3204158A1 (de) * 1982-02-06 1983-08-11 Dr. Karl Thomae Gmbh, 7950 Biberach "substituierte dibenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel"
EP0086591A1 (en) * 1982-02-10 1983-08-24 George Patrick Allnutt Apparatus for dispensing particulate materials
US4558132A (en) * 1982-07-02 1985-12-10 A. H. Robins Company, Incorporated Nitro, amino and aroylamino-N-phenylpyridinamines in a process for preparing pyrido[1,4]benzodiazepines
IT1212742B (it) * 1983-05-17 1989-11-30 Dompe Farmaceutici Spa Derivati dibenzo [1,4]diazepinonici pirido [1,4] benzodiazepinonici,pirido [1,5] benzodiazepinonici e loro attivita' farmacologica

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333315A1 (en) * 1988-02-12 1989-09-20 Dr. Lo. Zambeletti S.p.A. Azacyclic compounds, processes for their preparation and their pharmaceutical use
EP0411567A1 (de) * 1989-07-31 1991-02-06 ARZNEIMITTELWERK DRESDEN GmbH Neue 5-(omega-Aminoacyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]-diazepin-11-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO1991017116A1 (en) * 1990-04-28 1991-11-14 Dr. Lo. Zambeletti S.P.A. Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
US5428042A (en) * 1990-04-28 1995-06-27 Dr Lo Zambeletti S.P.A. 1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa agonists
EP0515796A1 (de) * 1991-05-25 1992-12-02 ARZNEIMITTELWERK DRESDEN GmbH Neue 5-Aminoacyl-5.10-dihydro-11H-dibenzo/b,e/1,4/diazepin-11-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NO850992L (no) 1985-09-16
NO161371B (no) 1989-05-02
DK171023B1 (da) 1996-04-22
IE58237B1 (en) 1993-08-11
ES8607282A1 (es) 1986-05-16
AU571315B2 (en) 1988-04-14
NZ211425A (en) 1988-03-30
CS409691A3 (en) 1992-09-16
PT80097B (pt) 1987-10-20
FI81342C (fi) 1990-10-10
ES541212A0 (es) 1986-05-16
CA1244016A (en) 1988-11-01
ES551276A0 (es) 1986-12-01
IL74573A0 (en) 1985-06-30
ATE44744T1 (de) 1989-08-15
KR920003980B1 (ko) 1992-05-21
KR850006403A (ko) 1985-10-05
DD235260A5 (de) 1986-04-30
AU3981585A (en) 1985-09-19
ES8701750A1 (es) 1986-12-01
HU192272B (en) 1987-05-28
EP0156191A2 (de) 1985-10-02
GR850612B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-07-11
DK114985A (da) 1985-09-15
PT80097A (de) 1985-04-01
DK114985D0 (da) 1985-03-13
US4550107A (en) 1985-10-29
JPS60215683A (ja) 1985-10-29
NO161371C (no) 1989-08-09
JPH0568474B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-09-29
ZA851871B (en) 1986-11-26
FI81342B (fi) 1990-06-29
MX9202791A (es) 1992-06-30
EP0156191B1 (de) 1989-07-19
DE3571620D1 (en) 1989-08-24
IE850645L (en) 1985-09-14
FI850991A0 (fi) 1985-03-13
EP0156191A3 (en) 1986-12-30
ES551277A0 (es) 1987-01-16
ES8702908A1 (es) 1987-01-16
PH21031A (en) 1987-06-30
HUT37611A (en) 1986-01-23
FI850991L (fi) 1985-09-15
IL74573A (en) 1988-05-31

Similar Documents

Publication Publication Date Title
EP0156191B1 (de) Kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE602004006891T2 (de) Derivate von n-äphenyl(pyrrolidin-2-yl)methylübenzamid und n-ä(azepan-2-yl)phenylmethylübenzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
DE69106532T2 (de) N-substituierte lactame als cholecystokinin-antagonisten.
EP1228060A1 (de) Arylalkane, arylalkene und aryl-azaalkane, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0254955B1 (de) Substituierte Pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0306698B1 (de) Neue kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD283141A5 (de) Verfahren zur herstellung kondensierter diazepinone
DE69311123T2 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
EP0344543B1 (de) Neue kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3643666A1 (de) Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD284016A5 (de) Verfahren zur herstellung von kondensierten diazepinonen
DE3819444A1 (de) Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69324794T2 (de) Phenyl imidazolinon-derivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht3-rezeptor-antagonisten
DE3523002A1 (de) Neue in 11-stellung substituierte 5,11-dihydro-6h-pyrido(2,3-b) (1,4)benzodiazepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0326066A2 (de) Neue kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD284015A5 (de) Verfahren zur herstellung von kondensierten diazepinonen
DE102004010254A1 (de) Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel

Legal Events

Date Code Title Description
8141 Disposal/no request for examination